Pros | ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() Among most bought funds within the category. ![]() Larger AUM within category. ![]() Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | ![]() 5Y returns in the bottom 25% of the category. ![]() 3Y returns in the bottom 25% of the category. |
INDMoney rank | 6/8 | 7/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 12 Years | 12 Years | ||
Fund Size | 1119 Cr | 8357 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 1.3% | 0.89% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 43 | 41 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (9.42%) Cipla Ltd (5.68%) Ajanta Pharma Ltd (5.38%) Lupin Ltd (4.57%) Dr Reddy's Laboratories Ltd (4.06%) | Sun Pharmaceuticals Industries Ltd (11.94%) Divi's Laboratories Ltd (7.34%) Cipla Ltd (6.09%) Lupin Ltd (6.09%) Apollo Hospitals Enterprise Ltd (5.91%) | ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors | Health (98.87%) Basic Materials (1.13%) | Health (100%) | ||
Equity % | 99.35% | 99.48% | ||
Debt % | - | - | ||
P/E | 37.41 | 36.11 | ||
P/B | 5.73 | 5.78 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.74% | -0.45% | ||
3-Month Return | 2.15% | -0.25% | ||
6-Month Return | 15.71% | 11.51% | ||
1-Year Return | 2.33% | -1.02% | ||
3-Year Return | 25.79% | 22.76% | ||
5-Year Return | 18.34% | 17.96% |
Sharpe | 1.09 | 0.95 | ||
Alpha | 1.95 | -0.12 | ||
Beta | 0.95 | 0.91 | ||
Standard Deviation | 15.79 | 15.23 | ||
Information Ratio | 0.49 | -0.44 |
Description | UTI Healthcare Fund-Growth Option- Direct is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund - Direct Plan - Growth Plan is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Kamal Gada | Sailesh Raj Bhan,Kinjal Desai |